Tectonic Therapeutic, Inc.
TECX
$17.02
-$0.54-3.08%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 16.65M | 14.00M | 10.66M | 8.18M | 7.57M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 58.02M | 53.40M | 43.88M | 43.09M | 44.65M |
Operating Income | -58.02M | -53.40M | -43.88M | -43.09M | -44.65M |
Income Before Tax | -57.98M | -53.48M | -45.82M | -43.60M | -42.82M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -57.98 | -53.48 | -45.82 | -43.60 | -42.82 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -57.98M | -53.48M | -45.82M | -43.60M | -42.82M |
EBIT | -58.02M | -53.40M | -43.88M | -43.09M | -44.65M |
EBITDA | -56.37M | -51.89M | -42.42M | -41.60M | -43.17M |
EPS Basic | -12.21 | -17.26 | -23.68 | -27.85 | -28.52 |
Normalized Basic EPS | -7.63 | -10.79 | -14.80 | -17.41 | -17.82 |
EPS Diluted | -12.21 | -17.26 | -23.68 | -27.85 | -28.52 |
Normalized Diluted EPS | -7.63 | -10.79 | -14.80 | -17.41 | -17.82 |
Average Basic Shares Outstanding | 35.05M | 21.59M | 8.18M | 6.49M | 6.11M |
Average Diluted Shares Outstanding | 35.05M | 21.59M | 8.18M | 6.49M | 6.11M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |